Improving chronic disease care in South Tyrol with a new health tool
Not Applicable
- Conditions
- Perceived quality of care of patients with a diagnosis of chronic obstructive pulmonary disease (COPD), asthma, T2DM, and/or heart failureNot Applicable
- Registration Number
- ISRCTN13531607
- Lead Sponsor
- andesfachhochschule für Gesundheitsberufe Claudiana
- Brief Summary
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38509576/ (added 22/03/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 354
Inclusion Criteria
1. Patients with a diagnosis of chronic obstructive pulmonary disease (COPD), asthma, T2DM, and/or heart failure
2. Can understand and read German or Italian
Exclusion Criteria
1. Patients with asthma or COPD who have taken prednisone for an exacerbation within 6 weeks prior to the start of the study
2. Patients with T2DM or heart failure who have been hospitalised within 6 weeks prior to the start of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The shift in perceived quality of care over an 18-month period, measured using the Patient Assessment of Chronic Illness Care (PACIC) questionnaire at baseline, 6, 12, and 18 months
- Secondary Outcome Measures
Name Time Method 1. Shift in perceived quality of care, individually for each chronic condition, measured using the PACIC questionnaire at baseline, 6, 12, and 18 months<br>2. Perceived quality of care against regular care, both for the entire participant group and individually for each chronic condition, measured using the PACIC questionnaire at 6- and 12-month intervals<br>3. Universal health-related quality of life, measured using the EQ-5D-5L questionnaire, compared to standard care, both for the entire participant group and for each chronic condition separately at 6, 12, and 18-month intervals<br>4. Participant activation measured using the Patient Activation Measure (PAM) compared to standard care, both for the entire participant group and individually for each chronic condition, at 6, 12, and 18-month intervals<br>5. Cost-effectiveness analysis of the ABCC tool compared to usual care, focusing on direct medical costs reimbursed by the National Health Service, after an 18-month period